Tumor organoids - expert interview

Tumor organoids are redefining cancer research. Our experts join BioTechniques to discuss future trends in cancer biology and personalized medicine.

Organoid models of patient-specific tumors are transforming our understanding of cancer heterogeneity and its implications for personalized medicine.

Read the interview with BioTechniques where our experts Janina Moros, Dr. Alexander Trampe and Dr. Zinnia Noor discuss their views on:

  • The benefits of tumor organoids
  • How to establish and culture tumor organoids
  • Applications of tumor organoids across different areas of cancer biology

Download the white paper

Fill in the form to download the PDF.

Recommended products

Endothelial Cell Growth Medium 2

Endothelial Cell Growth Medium 2

Low-serum cell culture medium for endothelial cells from large blood vessels. Formulation free of bovine hypothalamic extract.
$110.00
Endothelial Cell Growth Medium MV

Endothelial Cell Growth Medium MV

Low-serum cell culture medium for endothelial cells from microvascular vessels, the coronary artery, and the aorta.
$113.00
Endothelial Cell Growth Medium MV2

Endothelial Cell Growth Medium MV2

Low-serum cell culture medium for endothelial cells from microvascular vessels, the coronary artery, and the aorta. Formulation free of bovine hypothalamic extract.
$113.00
Human Umbilical Vein Endothelial Cells (HUVEC)

Human Umbilical Vein Endothelial Cells (HUVEC)

Primary Human Umbilical Vein Endothelial Cells isolated from the vein of the umbilical cord of single, pooled or pre-screened donors.
$276.00
Human Umbilical Vein Endothelial Cells 2 (HUVEC 2)

Human Umbilical Vein Endothelial Cells 2 (HUVEC 2)

HUVEC isolated from the umbilical vein of single, pooled or pre-screened donors in Endothelial Cell Growth Medium 2 containing additional VEGF.
$277.00
Endothelial Cell Growth Medium

Endothelial Cell Growth Medium

Low-serum cell culture medium for endothelial cells from large blood vessels.
$110.00
Copyright © 2013-present Magento, Inc. All rights reserved.